Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ISONIAZID TABLETS

Closed
SPE2DP-26-T-4484Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

ISONIAZID TABLETS, 300 MG, are procured under solicitation SPE2DP-26-T-4484 as a Type I (Code Q) medical item with a non-extendable shelf life of 36 months and must be stored at controlled room temperature. The item is regulated by the FDA and requires prior confirmation through EBS referral by the contracting official, including manufacturer and product details. Packaging must comply with DLA’s Master List of Technical and Quality Requirements, MIL-STD-129 marking standards, and RP001 packaging specifications, with the unit of issue being a bottle. The product must be free of intentional mercury or mercury compounds except in specific exempted applications, and portable devices containing mercury must meet Navy safety standards. Delivery is FOB destination within 20 days of the required delivery date of August 6, 2026, with zero tolerance for quantity variance. Shipment must be traceable and cannot use parcel post; the delivery address is DLA Distribution Pearl Harbor, Building 1900, Pearl Harbor, HI. Packaging must meet ASTM D3951 for non-hazardous materials, but DLA technical requirements take precedence. Two approved manufacturers are listed with their respective NDC numbers, and all labeling and palletization must adhere strictly to DLA guidelines.

General Info

ISONIAZID 300 MG tablets procured under SPE2DP-26-T-4484, FOB destination by Aug 6, 2026, with strict DLA packaging and labeling rules.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

2000 GAFFNEY ST BLDG 1900, PEARL HARBOR, HI, 96860-4518, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4484 for Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
ISONIAZID TABLETS
ISONIAZID TABLETS<(>,<)> USP, 300 MG,100'S UNIT OF ISSUE "BOTTLE". Store at medical controlled room temperature.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135080501 GENUS LIFESCIENCES INC 7BH52 P/N NDC64950-0217-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4484
SECTION B
PR: 7017720398 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017720398 0001 BT 1.000
NSN/MATERIAL:6505001326904
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
SW3144
DLA DISTRIBUTION PEARL HARBOR
RECEIVING OFFICER
2000 GAFFNEY ST BLDG 1900
PEARL HARBOR HI 96860-4518
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
SW3144
DLA DISTRIBUTION PEARL HARBOR
RECEIVING OFFICER
2000 GAFFNEY ST BLDG 1900
PEARL HARBOR HI 96860-4518
US
M/F: (TCN) N241336212S391
RDD: 226
PROJ: HJ5 TP 3
SUPP ADD: SW3144 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 15
DIC: A4A DIST: U9B ADV: 2A FC: E5
SPE2DP-26-T-4484
SECTION B
PR: 7017720398 PRLI: 0001 CONT’D
Need Ship Date:00/00/0000 Original Required Delivery Date:08/06/2026
SPE2DP-26-T-4484 NSN/Part Number: 6505-00-132-6904 Quantity: 1 BT Purchase Request: 7017720398QTY: 1 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS